Publication:
Novel coronavirus 2019 infections current status

dc.contributor.buuauthorYeşil, Edanur
dc.contributor.buuauthorYEŞİL, EDANUR
dc.contributor.buuauthorHacımustafaoğlu, Mustafa
dc.contributor.buuauthorHACIMUSTAFAOĞLU, MUSTAFA KEMAL
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı.
dc.contributor.orcid0000-0002-8926-9959
dc.contributor.orcid0000-0003-4646-660X
dc.contributor.researcheridGSO-3630-2022
dc.contributor.researcheridJCD-9679-2023
dc.date.accessioned2024-07-05T12:07:34Z
dc.date.available2024-07-05T12:07:34Z
dc.date.issued2020-04-01
dc.description.abstractCoronaviruses are enveloped RNA viruses that take their name from the thorny protrusions (Corona; Crown) on their surface in electron microscopy.They can cause respiratory,enteric,hepatic, and neurological diseases in humans and animals.Human infections are usually caused by Alpha and Beta types. Human Coronaviruses (HCoV) were first described in the 1960s,and these are mainly 229E,NL63,OC43 and HKU1 Coronaviruses, causing typical mild/moderate respiratory diseases in humans.In addition,occasional outbreaks of different severe Coronavirus infections (MERS-CoV,SARS-CoV) have been reported.Apart from these,new(novel) Coronavirus infections (2019-nCoV, SARS-CoV-2 or COVID-19) have been reported which started in Wuhan,Hubei,China in December 2019 and tend to spread all over the world.In this review,it is aimed to present the epidemiological course,genetic factors,transmission,prevention of this novel Coronavirus infections with the clinical findings in adults and children,diagnosis,treatment,prevention methods and current information in our country.As of February 12,2020, 45.171 proven cases have been reported in the world and 25 different countries have been affected by this epidemic.The average incubation period of COVID-19 infection was 5.2days (1-14 days).The fatality rate was 2.5% on average in all cases,but 4.3-15% in severe or hospitalized patients.In adult cases,it begins clinically with nonspecific upper respiratory tract infections such as fever,cough and weakness.In severe cases,symptoms such as pneumonia and severe respiratory failure develop within days.In laboratory findings;lymphopenia was observed in hospitalized patients,lung involvement was in almost all cases with bilateral and multilobuler and/or subsegmental consolidation. Pediatric cases were usually asymptomatic or with mild upper respiratory tract infection findings. Pneumonia has been rarely seen.Mortality has not been reported in pediatric cases.Treatment of COVID-19 mainly consists of supportive therapy. Droplet isolation measures and hand hygiene play an important role in protection.Rigorous application of infection control measures is expected to be helpful in breaking the epidemics and pandemics.
dc.identifier.endpage139
dc.identifier.issn1304-9054
dc.identifier.issue1
dc.identifier.startpage125
dc.identifier.urihttps://hdl.handle.net/11452/42988
dc.identifier.volume18
dc.identifier.wos000527262100014
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherGalenos Publ House
dc.relation.journalGuncel Pediatri-journal Of Current Pediatrics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectChina
dc.subjectCoronavirus
dc.subjectCovid-19
dc.subjectPandemic
dc.subjectSars-cov-2
dc.subject2019-ncov
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectPediatrics
dc.titleNovel coronavirus 2019 infections current status
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication0b3ea774-8949-40c0-8320-c0d25bcc0247
relation.isAuthorOfPublication0f1ad7e3-4cce-40b2-bbb3-7200fae5f769
relation.isAuthorOfPublication.latestForDiscovery0b3ea774-8949-40c0-8320-c0d25bcc0247

Files

Collections